Skip to main content
. 2021 Oct 25;11(11):1081. doi: 10.3390/jpm11111081

Table 4.

Treatment outcomes for all patients with cavitary and non-cavitary TB.

Outcomes All Patients
(n = 410)
Non-Cavitary TB
(n = 244)
Cavitary TB
(n = 166)
p-Value
AFB culture results at month 2 <0.030
Positive 12 (2.9) 4 (1.6) 8 (4.8)
Negative 166 (40.5) 93 (38.1) 73 (44.0)
Not performed 232 (56.6) 147 (60.2) 85 (51.2)
Treatment duration, days 236 (102–370) 202 (98–336) 248 (134–392) <0.001
Treatment outcomes 0.062
Cured/treatment
completed
385 (93.9) 204 (83.7) 151 (91.0)
Treatment failure 0 (0) 0 (0) 0 (0)
Lost to follow up 11 (2.7) 7 (2.9) 4 (2.4)
Not evaluated 44 (10.7) 33 (13.5) 11 (6.6)
Recurrence after treatment
success
6 (1.5) 1 (0.4) 5 (3.0) 0.042
Favorable treatment
outcomes
348 (84.9) 203 (83.2) 145 (87.3) 0.249
Unfavorable treatment
outcomes
6 (1.5) 1 (0.4) 5 (3.0) 0.042

The data are presented as mean and standard deviation or number and percentage, as appropriate. AFB: acid-fast bacilli; TB: tuberculosis.